Treating inflammation is the next big breakthrough in fighting cardiovascular disease.
Our therapeutic antibody ATH3G10 is a first-in-class candidate.
Inflammation in vascular diseases is significant but is not specifically addressed by current therapies. Athera is developing one…
learn more
